百日咳ワクチン市場レポート：2030年までの動向、予測、競合分析

百日咳ワクチンの動向と予測

世界の百日咳ワクチン市場は、2024年から2030年までのCAGRが5.6%で、2030年までに推定91億米ドルに達すると予測されます。この市場の主な促進要因は、百日咳ワクチン接種の重要性に対する意識の高まり、百日咳ワクチン接種を促進するための政府の支援策、新しい百日咳ワクチンの継続的な開発です。世界の百日咳ワクチン市場の将来性は、ワクチン接種センター、病院、診療所市場でのビジネスチャンスにより有望視されています。

百日咳ワクチン市場の洞察

Lucintelは、ジフテリア、破傷風、百日咳を予防する混合ワクチンとして重要な用途があるため、Dtapが引き続き大きなセグメントを占めると予測しています。

北米は、老年人口の増加と百日咳死亡例の増加により、予測期間中に最も高い成長が見込まれます。

市場規模・推計：百日咳ワクチンの市場規模を金額（Bドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメント別分析：百日咳ワクチンの市場規模をタイプ別、エンドユース別、地域別に金額（億米ドル）で推計。

地域別分析：百日咳ワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。

成長機会：百日咳ワクチンの種類、最終用途、地域別の成長機会分析。

戦略分析：百日咳ワクチン市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の百日咳ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界の百日咳ワクチン市場動向（2018年～2023年）と予測（2024年～2030年）
• タイプ別の世界の百日咳ワクチン市場
  • Dtapワクチン
  • Tdapワクチン
• 最終用途別の世界の百日咳ワクチン市場
  • 予防接種センター
  • 病院
  • クリニック
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の百日咳ワクチン市場
• 北米の百日咳ワクチン市場
• 欧州の百日咳ワクチン市場
• アジア太平洋の百日咳ワクチン市場
• その他の地域の百日咳ワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別の世界の百日咳ワクチン市場の成長機会
  • 最終用途別の世界の百日咳ワクチン市場の成長機会
  • 地域別の世界の百日咳ワクチン市場の成長機会
• 世界の百日咳ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の百日咳ワクチン市場の生産能力拡大
  • 世界の百日咳ワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Protein Sciences
• GlaxoSmithKline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Pertussis Vaccine Trends and Forecast

The future of the global pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets. The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

A more than 150-page report is developed to help in your business decisions.

Pertussis Vaccine by Segment

The study includes a forecast for the global pertussis vaccine by type, end use, and region.

Pertussis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dtap Vaccine
• Tdap Vaccine

Pertussis Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Vaccination Centers
• Hospitals
• Clinics
• Others

Pertussis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pertussis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pertussis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pertussis vaccine companies profiled in this report include-

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Pertussis Vaccine Market Insights

Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Features of the Global Pertussis Vaccine Market

Market Size Estimates: Pertussis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pertussis vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Pertussis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the pertussis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pertussis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pertussis vaccine market size?

Answer: The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for pertussis vaccine market?

Answer: The global pertussis vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pertussis vaccine market?

Answer: The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

Q4. What are the major segments for pertussis vaccine market?

Answer: The future of the pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets.

Q5. Who are the key pertussis vaccine market companies?

Answer: Some of the key pertussis vaccine companies are as follows:

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Q6. Which pertussis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

Q7. In pertussis vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pertussis vaccine market by type (Dtap vaccine and Tdap vaccine), end use (vaccination centers, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pertussis Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pertussis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pertussis Vaccine Market by Type
  • 3.3.1: Dtap Vaccine
  • 3.3.2: Tdap Vaccine
• 3.4: Global Pertussis Vaccine Market by End Use
  • 3.4.1: Vaccination Centers
  • 3.4.2: Hospitals
  • 3.4.3: clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pertussis Vaccine Market by Region
• 4.2: North American Pertussis Vaccine Market
  • 4.2.2: North American Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.3: European Pertussis Vaccine Market
  • 4.3.1: European Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.3.2: European Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.4: APAC Pertussis Vaccine Market
  • 4.4.1: APAC Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.4.2: APAC Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.5: ROW Pertussis Vaccine Market
  • 4.5.1: ROW Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.5.2: ROW Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pertussis Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pertussis Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Pertussis Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pertussis Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pertussis Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pertussis Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Protein Sciences
• 7.2: GlaxoSmithKline
• 7.3: Sanofi Pasteur
• 7.4: Seqirus
• 7.5: Merck Sharp & Dohme
• 7.6: Novartis
• 7.7: Astellas Pharma